Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Jérôme, Verine"'
Autor:
Joëlle Razafimahefa, Clément Gosset, Pierre Mongiat-Artus, Tsitohery Francine Andriamampionona, Jérôme Verine
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background The bone formation within bladder tumors could be encountered in 3 conditions. These might consist of malignant bone formation in mesenchymal tumors; mixed mesenchymal and epithelial tumors; and epithelial tumors with stromal osse
Externí odkaz:
https://doaj.org/article/dd3c68c851ef41f8996e16e3fe975911
Autor:
Guilhem Bousquet, Anne Janin, Pierre Mongiat-Artus, Stéphane Germain, Jérôme Verine, Arnaud Duval, Niclas Setterblad, Christophe Leboeuf, Irmine Ferreira, Sophie Tan, Philippe Ratajczak, Jean-Paul Feugeas, Guillaume Gapihan, Mariana Varna
Supplementary Table 1. Tumorigenic potential of cells sorted from normoxic and hypoxic spheres of the six xenograft models (take rate in percentage)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::046e42b8e68d1c809d22def3778d30eb
https://doi.org/10.1158/1078-0432.22461285.v1
https://doi.org/10.1158/1078-0432.22461285.v1
Autor:
Guilhem Bousquet, Anne Janin, Pierre Mongiat-Artus, Stéphane Germain, Jérôme Verine, Arnaud Duval, Niclas Setterblad, Christophe Leboeuf, Irmine Ferreira, Sophie Tan, Philippe Ratajczak, Jean-Paul Feugeas, Guillaume Gapihan, Mariana Varna
Figure S1. In the 6 models xenografted with human RCC, we identified 2 models responders to sunitinib and 4 non-responders. When treated with sunitinib, necrosis occurs earlier in the responder models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072b78f1115c7bd99bfdcae8b2cff78c
https://doi.org/10.1158/1078-0432.22461294
https://doi.org/10.1158/1078-0432.22461294
Autor:
Guilhem Bousquet, Anne Janin, Pierre Mongiat-Artus, Stéphane Germain, Jérôme Verine, Arnaud Duval, Niclas Setterblad, Christophe Leboeuf, Irmine Ferreira, Sophie Tan, Philippe Ratajczak, Jean-Paul Feugeas, Guillaume Gapihan, Mariana Varna
supplementary figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10db6b5b6aefe094061d3eb5031b078c
https://doi.org/10.1158/1078-0432.22461279.v1
https://doi.org/10.1158/1078-0432.22461279.v1
Autor:
Guilhem Bousquet, Anne Janin, Pierre Mongiat-Artus, Stéphane Germain, Jérôme Verine, Arnaud Duval, Niclas Setterblad, Christophe Leboeuf, Irmine Ferreira, Sophie Tan, Philippe Ratajczak, Jean-Paul Feugeas, Guillaume Gapihan, Mariana Varna
supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc22468a25a4e4a35ac50f37fac86aa
https://doi.org/10.1158/1078-0432.22461282.v1
https://doi.org/10.1158/1078-0432.22461282.v1
Autor:
Guilhem Bousquet, Anne Janin, Pierre Mongiat-Artus, Stéphane Germain, Jérôme Verine, Arnaud Duval, Niclas Setterblad, Christophe Leboeuf, Irmine Ferreira, Sophie Tan, Philippe Ratajczak, Jean-Paul Feugeas, Guillaume Gapihan, Mariana Varna
Purpose: Developing strategies to overcome resistance to sunitinib is a major challenge in human renal cell carcinoma (RCC). We hypothesized that sunitinib-induced tumor necrosis–associated hypoxia could interact with renal cancer stem cells in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db114e22c98eb5f70e25a45c5ed891b
https://doi.org/10.1158/1078-0432.c.6524751.v1
https://doi.org/10.1158/1078-0432.c.6524751.v1
Autor:
Julien Gras, Marie Laure Nere, Marie Noëlle Peraldi, Lucie Bonnet‐Madin, Maud Salmona, Jean Luc Taupin, François Desgrandchamps, Jérôme Verine, Etienne Brochot, Ali Amara, Jean Michel Molina, Constance Delaugerre
Publikováno v:
Transplant Infectious Disease. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc082110fa103402da34dd99b4303d61
https://doi.org/10.1111/tid.14012
https://doi.org/10.1111/tid.14012
Publikováno v:
Kidney International. 103:1205-1206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e108a30c0ad607afda4c07ee1e644f1a
https://doi.org/10.1016/j.kint.2023.01.005
https://doi.org/10.1016/j.kint.2023.01.005
Autor:
Alix Jacquier, François Desgrandchamps, Jérôme Verine, Joel LeMaoult, Jean-François Delattre, Clement Dumont, Malika Djouadou, Edgardo D. Carosella, Nathalie Rouas-Freiss, Tiphaine Lambert
Publikováno v:
Cancer Letters. 519:105-116
HLA-G:ILT2 has recently been positioned as a major immune checkpoint in urologic cancers. In clear cell renal cell carcinoma (ccRCC), tumor-infiltrating CD8+ T cells expressing ILT2 are a highly cytotoxic cell population, distinct from PD1+ T cells,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a6d88136ba58bd6ffcbd183d70d6ef
https://doi.org/10.1016/j.canlet.2021.06.018
https://doi.org/10.1016/j.canlet.2021.06.018
Autor:
Nathalie Rouas-Freiss, Joel LeMaoult, Jérôme Verine, Diana Tronik-Le Roux, Stéphane Culine, Christophe Hennequin, François Desgrandchamps, Edgardo D. Carosella
Publikováno v:
OncoImmunology, Vol 6, Iss 9 (2017)
The establishment and maintenance of anti-tumor immune responses are the objectives of cancer immunotherapy. Despite recent promising advances, the effectiveness of these approaches has been limited by the multiple immunosuppressive mechanisms develo
Externí odkaz:
https://doaj.org/article/24bec5a1fe454f17b18d7d18a72e8859